Clinical Trial Update: Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on the combination of olmesartan and hydrochlorothiazide for essential hypertension has completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• olmesartan and hydrochlorothiazide

Snippet

Sponsor: Daiichi Sankyo | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-06-17